SR
INSIDER · DNTH · Dianthus Therapeutics, Inc. /DE/ · EVP, CFO & CBO
Savitz Ryan
Every open-market transaction filed under this name, Nov 9 to Nov 12.
Filings
9
0 buys · 9 sells
Bought
—
open market, at cost
Sold
$11.2M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Nov 12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 17,724 | $90.56 | $1.6M | +1.4% |
| Nov 11 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 3,044 | $90.03 | $274K | +2.0% |
| Nov 10 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 2,561 | $90.14 | $231K | +1.9% |
| Nov 9 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 2,064 | $91.59 | $189K | +0.2% |
| Nov 9 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 58,396 | $90.90 | $5.3M | +1.0% |
| Nov 9 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 37,517 | $90.12 | $3.4M | +1.9% |
| Nov 9 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 1,736 | $88.84 | $154K | +3.3% |
| Nov 9 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 700 | $86.70 | $61K | +5.9% |
| Nov 9 | DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sell | 300 | $85.16 | $26K | +7.8% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.